Comparison of the effects of intra-articular Hyaluronic Acid Versus Methyl Prednisolone Acetate in Iraqi patients with Knee Osteoarthritis; A Double-Blind Controlled Study
DOI:
https://doi.org/10.32007/jfacmedbaghdad3015Keywords:
Double blind, Hyaluronic acid, Intra-articular, Methylprednisolone, OsteoarthritisAbstract
ABSTRACT :
Background: Osteoarthritis is a prevalent chronic joint condition that occurs when the cartilage, which acts as a low-friction surface between the joints, deteriorates, resulting in pain, stiffness, and swelling. There has been controversy about the effectiveness and tolerability of corticosteroids and hyaluronic acid, and about the superiority of one over the other in treating OA.
Objective current study aimed to compare the efficacy and safety of hyaluronic acid (HA) and methylprednisolone (MP) in the treatment of OA. Methods: One hundred and four patients with OA were randomized to receive intra-articular injection of either HA or MP, and they were followed for 3 months. Each patient from each group received a single injection at the time of enrollment. The participants and the evaluator were blinded to the nature of the injected material. The primary outcomes were to measure the change from baseline in Western Ontario McMaster University Osteoarthritis (WOMAC) index and visual analogue pain scale, and to record any treatment-related adverse events. Results: there were 49 females and 3 males in the HA group (mean age 59 ± 15.5) and 46 females and 6 males in the MP group (mean age 63 ± 15.5). Both groups demonstrated improvements in WOMAC and VAS scores throughout the follow-up period. The effect size for WOMAC and VAS scores favored HA over MP from month 2 to month 3 (P < 0.05). Both interventions were relatively safe, and no serious adverse events were reported. Conclusion: the results showed that both interventions are effective in relieving pain and improving knee stiffness and physical function. Furthermore, the current study showed that the most important difference between the two interventions is the duration of effectiveness. The benefit of HA was maintained to 3 months while that of MP declined after 1 month.
Downloads
References
1. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 american college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020 Feb;72(2):220-33.
https://doi.org/10.1002/art.41142.
2. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet. 2020 Nov 28;396(10264):1711-2.
https://doi.org/10.1016/S0140-6736(20)32230-3.
3. Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020 Dec;29-30:100587. https://doi.org/10.1016/j.eclinm.2020.100587.
4. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019 Apr 27;393(10182):1745-59. DOI: 10.1016/S0140-6736(19)30417-9.
https://doi.org/10.1016/S0140-6736(19)30417-9.
5. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003 Jan 14;5(2):54-67. https://doi.org/10.1186/ar623.
6. Han S-B, Seo I-W, Shin Y-S. Intra-Articular Injections of Hyaluronic Acid or Steroids Associated With Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis. Arthroscopy. 2021 Jan;37(1):292-306. https://doi.org/10.1016/j.arthro.2020.03.041.
7. Bucci J, Chen X, LaValley M, Nevitt M, Torner J, Lewis CE, et al. Progression of knee osteoarthritis with use of intraarticular glucocorticoids versus hyaluronic acid. Arthritis Rheumatol. 2022 Feb;74(2):223-6. https://doi.org/10.1002/art.42031.
8. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014 Mar;22(3):363-88. https://doi.org/10.1016/j.joca.2014.01.003.
9. He W-W, Kuang M-J, Zhao J, Sun L, Lu B, Wang Y, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. Int J Surg. 2017 Mar;39:95-103. https://doi.org/10.1016/j.ijsu.2017.01.087.
10. Xue Y, Wang X, Wang X, Huang L, Yao A, Xue Y. A comparative study of the efficacy of intra-articular injection of different drugs in the treatment of mild to moderate knee osteoarthritis: A network meta-analysis. Medicine (Baltimore). 2023 Mar 24;102(12):e33339.
https://doi.org/10.1097/MD.0000000000033339.
11. Yaftali NA, Weber K. Corticosteroids and hyaluronic acid injections. Clin Sports Med. 2019 Jan;38(1):1-15.
https://doi.org/10.1016/j.csm.2018.08.006.
12. Tammachote N, Kanitnate S, Yakumpor T, Panichkul P. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial. J Bone Joint Surg Am. 2016 Jun 1;98(11):885-92. https://doi.org/10.2106/JBJS.15.00544.
13. Ran J, Yang X, Ren Z, Wang J, Dong H. Comparison of intra-articular hyaluronic acid and methylprednisolone for pain management in knee osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg. 2018 May;53:103-10.
https://doi.org/10.1016/j.ijsu.2018.02.065.
14. Guermazi M, Poiraudeau S, Yahia M, Mezganni M, Fermanian J, Habib Elleuch M, et al. Translation, adaptation and validation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) for an Arab population: the Sfax modified WOMAC. Osteoarthr Cartil. 2004 Jun;12(6):459-68. https://doi.org/10.1016/j.joca.2004.02.006.
15. Lomonte ABV, de Morais MGV, de Carvalho LO, Zerbini CA de F. Efficacy of Triamcinolone Hexacetonide versus Methylprednisolone Acetate Intraarticular Injections in Knee Osteoarthritis: A Randomized, Double-blinded, 24-week Study. J Rheumatol. 2015 Sep;42(9):1677-84. https://doi.org/10.3899/jrheum.150297.
16. Bisicchia S, Bernardi G, Tudisco C. HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up. Clin Exp Rheumatol. 2016 May 31;34(5):857-63. URL: https://www.researchgate.net/profile/CosimoTudisco/publication/303707998_HYADD_4_versus_methylprednisolone_acetate_in_symptomatic_knee_osteoarthritis_A_single-centre_single_blind_prospective_randomised_controlled_clinical_study_with_a_1-year_follow-up/links/590c26f9a6fdcc5d421ee53f/HYADD-4-versus-methylprednisolone-acetate-in-symptomatic-knee-osteoarthritis-A-single-centre-single-blind-prospective-randomised-controlled-clinical-study-with-a-1-year-follow-up.pdf.
17. Leighton R, Akermark C, Therrien R, Richardson JB, Andersson M, Todman MG, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthr Cartil. 2014 Jan;22(1):17-25. https://doi.org/10.1016/j.joca.2013.10.009.
18. Singh H, Knapik DM, Polce EM, Eikani CK, Bjornstad AH, Gursoy S, et al. Relative Efficacy of Intra-articular Injections in the Treatment of Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Am J Sports Med. 2022 Sep;50(11):3140-8. https://doi.org/10.1177/03635465211029659.
19. Housman L, Arden N, Schnitzer TJ, Birbara C, Conrozier T, Skrepnik N, et al. Intra-articular hylastan versus steroid for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2014 Jul;22(7):1684-92. DOI: 10.1007/s00167-013-2438-7
https://doi.org/10.1007/s00167-013-2438-7.
20. La Gatta A, Stellavato A, Vassallo V, Di Meo C, Toro G, Iolascon G, et al. Hyaluronan and derivatives: an in vitro multilevel assessment of their potential in viscosupplementation. Polymers (Basel). 2021 Sep 22;13(19). https://doi.org/10.3390/polym13193208.
21. Vaishya R, Pandit R, Agarwal AK, Vijay V. Intra-articular hyaluronic acid is superior to steroids in knee osteoarthritis: A comparative, randomized study. J Clin Orthop Trauma. 2017;8(1):85-8. https://doi.org/10.1016/j.jcot.2016.09.008.
22. Frizziero L, Pasquali Ronchetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthopaed Traumatol. 2002 Dec 1;3(2):89-96. DOI:
https://doi.org/10.1007/s101950200034.
23. Tasciotaoglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol. 2003 May;22(2):112-7. https://doi.org/10.1007/s10067-002-0690-1
24. Askari A, Gholami T, NaghiZadeh MM, Farjam M, Kouhpayeh SA, Shahabfard Z. Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail. Springerplus. 2016 Apr 12;5:442.
https://doi.org/10.1186/s40064-016-2020-0
25. Costa FR, Costa Marques MR, Costa VC, Santos GS, Martins RA, Santos M da S, et al. Intra-Articular Hyaluronic Acid in Osteoarthritis and Tendinopathies: Molecular and Clinical Approaches. Biomedicines. 2023 Mar 30;11(4). https://doi.org/10.3390/biomedicines11041061
26. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014 Jul 18;5(3):351-61. https://doi.org/10.5312/wjo.v5.i3.351
27. Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009 Dec 15;61(12):1704-11. https://doi.org/10.1002/art.24925
28. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005328. https://doi.org/10.1002/14651858.CD005328.pub2.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Mohammed J. Ibraheem, Mohammed AH. AL- Zobaidy, Sami S. AlTekreeti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution 4.0 International license..
